Rachelle Jacques
Biotech CEO developing and delivering transformative therapies to patients with rare diseases. More...
Greater Boston, Greater Boston, United States
*50 free lookup(s) per month.
No credit card required.
Rachelle Jacques’s Email rachelle.jacques@shire.com
Social Media
Rachelle Jacques’s Location Greater Boston, Greater Boston, United States
Rachelle Jacques’s Current Industry Uniqure Corbus Pharmaceuticals
Rachelle Jacques’s Prior Industry Akari Therapeutics | Enzyvant | Viela Bio | Shire | Baxalta | Baxter International | Dow Corning | Deloitte And Touche | Ernst And Young
Not the Rachelle Jacques you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Uniqure
Non Executive Director
2021-10-01 00:00:00 - Present
Corbus Pharmaceuticals
Non Executive Director
2019-04-01 00:00:00 - Present
Akari Therapeutics
President and CEO
2022-03-01 00:00:00 - 2024-05-01 00:00:00
Enzyvant
CEO
2019-02-01 00:00:00 - 2022-03-01 00:00:00
Viela Bio
Non Executive Director
2020-05-01 00:00:00 - 2021-02-01 00:00:00
Shire
Vice President, U.S. Hematology Marketing
2016-01-01 00:00:00 - 2017-06-01 00:00:00
Baxalta
Vice President US Hematology Marketing
2016-01-01 00:00:00 - 2016-01-01 00:00:00
Baxter International
Vice President, Business Operations, Global BioScience Business
2014-01-01 00:00:00 - 2015-01-01 00:00:00
Dow Corning
Finance, Portfolio and M&A Lead, Business and Technology Incubator
2012-01-01 00:00:00 - 2013-01-01 00:00:00
Deloitte And Touche
Senior Financial Auditor
1994-01-01 00:00:00 - 1995-01-01 00:00:00
Ernst And Young
Staff Financial Auditor and Tax Intern
1993-01-01 00:00:00 - 1994-01-01 00:00:00Skills
Languages
FAQ About Rachelle Jacques
-
Rachelle Jacques is located at
Greater Boston, Greater Boston, United States -
Rachelle Jacques is a Biotech CEO developing and delivering transformative therapies to patients with rare diseases. More than two decades as a global leader driving long-term, sustainable value to stakeholders, including investors. Experienced director currently serving on the board of two public biopharmaceutical companies. Extensive track record managing successful cultural and strategic transformations, creating effective governance frameworks, and providing leadership for spinoffs and integrations. Empowers and inspires high-performing, agile teams to solve problems, innovate solutions, build unique capabilities and add to the overall knowledge base in emerging biotech sectors. Strong global and U.S. background in strategic, cross-functional leadership roles spanning finance, business operations and commercial, including the successful launches of several novel therapies for rare diseases. A thought leader and vocal advocate for the advancement of medicines to address significant and urgent unmet needs in rare diseases. Founding member of the ARM Action for Equality Task Force. Frequent author and panelist in industry forums calling for a redefinition of best regulatory, manufacturing and commercial practices to enable emerging biotechnologies and therapies.
-
Rachelle Jacques currently works in the Uniqure | Corbus Pharmaceuticals |
-
No Languages Available
-
Rachelle Jacques has prior
experience in the following industries:
Akari Therapeutics | Enzyvant | Viela Bio | Shire | Baxalta | Baxter International | Dow Corning | Deloitte And Touche | Ernst And Young -
Rachelle Jacques has the following professional experience:
Uniqure | Corbus Pharmaceuticals | Akari Therapeutics | Enzyvant | Viela Bio | Shire | Baxalta | Baxter International | Dow Corning | Deloitte And Touche | Ernst And Young -
You can view Rachelle Jacques’s LinkedIn profile at LinkedIn URL
-
Rachelle Jacques’s work email
addresses are
rachelle.jacques@shire.com -
Uniqure | Corbus Pharmaceuticals |
People you may be interested in
-
Keri Jordan
-
Brunsvold Carla
Experienced Quality Assurance Test Lead with a demonstrated history of...
Operations Manager
